Literature DB >> 6102487

Ketotifen in adult asthma.

A J Dyson, A D Mackay.   

Abstract

The efficacy and adverse effects of ketotifen 1 mg twice daily and 2 mg twice daily were compared with placebo in 50 patients with atopic asthma in a multicentre, double-blind study. Ketotifen in the higher dosage caused a slight reduction in salbutamol usage and a modest improvement in breathing in patients not already receiving inhaled corticosteroids. The drug was ineffective in patients receiving inhaled corticosteroids. Drowsiness was a troublesome effect causing withdrawal from treatment or reduction of dosage in seven patients while receiving ketotifen compared with only three while receiving placebo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102487      PMCID: PMC1600936          DOI: 10.1136/bmj.280.6211.360

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Comparison between ketotifen and DSCG in bronchial challenge.

Authors:  R Pauwels; H Lamont; M Van Der Straeten
Journal:  Clin Allergy       Date:  1978-05

2.  The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.

Authors:  U Martin; D Römer
Journal:  Arzneimittelforschung       Date:  1978

3.  A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma.

Authors:  J B Howell; R E Altounyan
Journal:  Lancet       Date:  1967-09-09       Impact factor: 79.321

4.  Disodium chromoglycate in the treatment of allergic bronchial asthma.

Authors:  F Moran; J D Bankier; G Boyd
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

5.  Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma.

Authors:  L Craps; C Greenwood; P Radielovic
Journal:  Clin Allergy       Date:  1978-07

6.  A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate.

Authors:  A Wells; B Taylor
Journal:  Clin Allergy       Date:  1979-05
  6 in total
  11 in total

Review 1.  New drugs in respiratory disorders: I.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

2.  Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators.

Authors:  O E Brodde; U Howe; S Egerszegi; N Konietzko; M C Michel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Ketotifen and asthma.

Authors:  J K Sarsfield
Journal:  Arch Dis Child       Date:  1981-04       Impact factor: 3.791

4.  Drugs for asthma: mast-cell stabilisers.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

5.  Drugs for asthma: mast-cell stabilisers.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

6.  A trial of ketotifen in intrinsic asthma.

Authors:  M I Ullah; J Brostoff; K B Saunders
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

7.  Ketotifen in atopic asthma and exercise-induced asthma.

Authors:  I S Petheram; J Moxham; C W Bierman; M McAllen; S G Spiro
Journal:  Thorax       Date:  1981-04       Impact factor: 9.139

8.  Evaluation of ketotifen (HC20-511) in bronchial asthma.

Authors:  J W Paterson; R H Yellin; R A Tarala
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Comparative clinical evaluation of ketotifen and montelukast sodium in asthmatic Iraqi patients.

Authors:  Fadyia Y Al-Hamdani
Journal:  Saudi Pharm J       Date:  2010-07-29       Impact factor: 4.330

10.  Ketotifen and nocturnal asthma.

Authors:  J R Catterall; P M Calverley; J T Power; C M Shapiro; N J Douglas; D C Flenley
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.